Research on conductive polymer microneedles with adjustable dissolution rate
Source abstract
Abstract
Dissolvable polymeric microneedles have gained significant attention in recent years as a promising transdermal drug delivery method due to their simple fabrication and lack of medical waste after use. However, traditional polymeric microneedles possess several notable drawbacks, including insufficient mechanical strength, difficulty in effectively penetrating the skin barrier, limited drug loading capacity affecting therapeutic outcomes, and uncontrollable drug release rates leading to unstable efficacy. In this paper, a conductive polymer microneedle with an adjustable dissolution rate is proposed. The dissolution rate of microneedles can be adjusted by controlling the current so as to control the drug release rate and realize the controlled drug release truly. The PVA-Ag and PVP-Ag lidocaine-loaded microneedles demonstrated good puncture performance and nearly complete dissolution within 10 min in a simulated body fluid environment. The dissolution rate was significantly accelerated under electrical stimulation. The microneedles showed good biocompatibility, and under the application of a 3 V voltage, the drug delivery efficiency of PVP-Ag lidocaine microneedles reached 85% within 5 min, while PVA-Ag lidocaine microneedles achieved up to 90%.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Textile materials and evaluations · Contact Dermatitis and Allergies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jiangxi Province Key Laboratory of Precision Drive and Control, Nanchang Institute of Technology , Nanchang 330099,
Funding
National Natural Science Foundation of China
References (17)
Show source-provided references
1. Microneedle arrays for drug delivery and diagnostics: Toward an optimized design, reliable insertion, and penetration10.1002/admi.202101856 ↗
2. Microneedle technology: An insight into recent advancements and future trends in drug and vaccine delivery10.1089/adt.2020.1022 ↗
3. Microneedles in action: Microneedling and microneedles-assisted transdermal delivery10.3390/polym14081608 ↗
4. Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity10.1016/j.vaccine.2020.07.064 ↗
5. Advances in the application of soluble polymer microneedles in drug delivery of eye diseases10.3760/cma.j.cn112142-20230523-00212. ↗
6. Microneedles with controlled bubble sizes and drug distributions for efficient transdermal drug delivery10.1038/srep38755 ↗
7. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery10.1016/j.jconrel.2016.08.031 ↗
8. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine10.1016/j.jconrel.2018.08.017 ↗
9. Antibacterial and angiogenic chitosan microneedle array patch for promoting wound healing10.1016/j.bioactmat.2020.02.004 ↗
10. Chitosan-based microneedles as a potential platform for drug delivery through the skin: Trends and regulatory aspects10.1016/j.ijbiomac.2021.06.059 ↗
11. Combined silk fibroin microneedles for insulin delivery10.1021/acsbiomaterials.0c00273 ↗
12. Progress of polymer microneedles on transdermal drug delivery10.11777/j.issn1000-3304.2022.22001 ↗
13. Advances in microneedle-mediated transdermal delivery of biomacromolecular drugs10.20053/j.issn1001-5094.2024.04.003 ↗
14. Advances in microneedle-based approaches for skin diseases: A comprehensive review of therapeutic applications and future perspectives10.2174/2211352521666230911155555 ↗
15. Advances of microneedle system in tumor vaccines10.11669/cpj.2023.15.001 ↗
16. Dissolvable polymer microneedles for drug delivery and diagnostics10.1016/j.jconrel.2022.04.043 ↗
17. Microneedle array penetration tests: Understanding the “bed of nails” phenomenon